TD Cowen lowered the firm’s price target on Bruker (BRKR) to $43 from $53 and keeps a Hold rating on the shares. The firm said they reported disappointing Q4 earnings, margins and free cash flow while offering a very weak guida, leaving a steep ramp needed to reach the 2026 guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: